(Q35057326)

6 August 2017

title

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study (English)

1 reference

6 August 2017

0 references

Jacqueline A French

3

0 references

Anuradha Ganesan

7

object named as

Anuradha Ganesan

1 reference

6 August 2017

10

Tahaniyat Lalani

1 reference

6 August 2017

8

Amy C Weintrob

1 reference

6 August 2017

Nancy F Crum-Cianflone

9

object named as

Nancy Crum-Cianflone

1 reference

6 August 2017

1

Jason F Okulicz

1 reference

6 August 2017

Greg A Grandits

2

1 reference

6 August 2017

Jomy M George

4

1 reference

6 August 2017

David M Simpson

5

1 reference

6 August 2017

Gretchen L Birbeck

6

1 reference

6 August 2017

Michael L Landrum

11

1 reference

6 August 2017

Infectious Disease Clinical Research Program (IDCRP) HIV Working Group

12

1 reference

6 August 2017

publication date

16 May 2011

1 reference

AIDS Research and Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

page(s)

18

1 reference

https://scigraph.springernature.com/pub.10.1186/1742-6405-8-18

6 August 2017

exact match

0 references

cites work

Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Maraviroc: a review of its use in the management of CCR5-tropic HIV-1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Therapeutic drug monitoring of antiretrovirals for people with HIV

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Update on rifampin and rifabutin drug interactions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Neurological complications of HIV infection.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Anticonvulsant and antiretroviral interactions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Potential interaction between ritonavir and carbamazepine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Seizures in human immunodeficiency virus infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3119192

Frequency of seizures and epilepsy in neurological HIV-infected patients.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-8-18

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-8-18

Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-8-18

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-6405-8-18

Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21575228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1742-6405-8-18

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference